Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 60.83%749.87M | 28.35%2.62B | 22.66%1.84B | 7.36%1B | 13.09%466.25M | -29.17%2.04B | -32.66%1.5B | -37.47%931.79M | -47.29%412.29M | -13.95%2.88B |
Refunds of taxes and levies | 176.17%100.82M | 13.99%174.98M | 15.43%138.45M | 2.00%81.85M | 6.27%36.5M | -44.87%153.5M | -47.40%119.93M | -54.02%80.24M | -62.73%34.35M | -21.52%278.45M |
Cash received relating to other operating activities | 65.67%37M | 17.57%127.32M | 40.08%92.09M | 4.72%54.57M | -36.59%22.34M | -41.30%108.3M | -5.86%65.74M | -23.26%52.11M | -19.95%35.23M | 189.76%184.49M |
Cash inflows from operating activities | 69.06%887.69M | 26.88%2.92B | 22.82%2.07B | 6.83%1.14B | 8.97%525.09M | -31.15%2.3B | -33.25%1.69B | -38.58%1.06B | -47.53%481.87M | -11.22%3.34B |
Goods services cash paid | 58.98%820.1M | 36.16%2.46B | 22.24%1.7B | 5.54%974.34M | 7.38%515.84M | -29.76%1.81B | -28.35%1.39B | -28.81%923.19M | -37.58%480.39M | -24.95%2.57B |
Staff behalf paid | 18.33%59.95M | 3.67%117.48M | 2.81%88.6M | 1.35%71.92M | -8.47%50.67M | 2.43%113.32M | -13.07%86.17M | -2.38%70.96M | -0.75%55.36M | -3.30%110.64M |
All taxes paid | 101.98%17.63M | 3.55%33.92M | -4.49%24.64M | 3.29%14.94M | 52.13%8.73M | -63.67%32.75M | -66.37%25.8M | -66.94%14.47M | -76.01%5.74M | 182.21%90.15M |
Cash paid relating to other operating activities | 46.56%61.15M | 30.83%261.92M | 50.81%176.63M | 30.94%111.84M | 16.39%41.73M | -23.56%200.2M | -27.73%117.12M | -42.08%85.42M | -49.56%35.85M | 41.29%261.89M |
Cash outflows from operating activities | 55.41%958.84M | 33.46%2.87B | 22.85%1.99B | 7.22%1.17B | 6.86%616.97M | -29.06%2.15B | -28.92%1.62B | -29.90%1.09B | -37.27%577.34M | -19.26%3.04B |
Net cash flows from operating activities | 22.56%-71.15M | -69.62%44.55M | 22.22%82.8M | -21.17%-36.23M | 3.76%-91.88M | -51.91%146.66M | -72.82%67.75M | -117.40%-29.9M | -4,496.86%-95.47M | 11,145.93%304.95M |
Investing cash flow | ||||||||||
Cash received from returns on investments | -82.49%388.95K | -45.83%4.12M | -65.18%6.37M | -55.55%4.37M | -15.49%2.22M | -42.83%7.6M | 292.72%18.28M | 308.50%9.82M | 29.47%2.63M | -40.20%13.3M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | 16.94%30K | ---- | ---- | ---- | -93.46%25.66K | -49.85%263.81K | ---- | ---- | -16.99%392.52K |
Cash received relating to other investing activities | -20.58%256.85M | -13.28%1.21B | -22.20%803.74M | 0.37%626.74M | -14.99%323.42M | -10.69%1.39B | -10.28%1.03B | -22.55%624.45M | 19.79%380.46M | 3.42%1.56B |
Cash inflows from investing activities | -21.01%257.24M | -13.46%1.21B | -22.97%810.11M | -0.50%631.11M | -14.99%325.64M | -10.98%1.4B | -9.08%1.05B | -21.62%634.27M | 19.69%383.09M | 2.78%1.57B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 88.57%29.71M | -20.43%83.83M | -42.39%58.3M | -21.76%37.98M | -12.17%15.76M | 130.69%105.35M | 218.33%101.2M | 344.33%48.54M | 466.21%17.94M | -31.67%45.67M |
Cash paid relating to other investing activities | -1.52%276.88M | -21.70%1.02B | -29.65%682.4M | -18.68%460.35M | -27.08%281.16M | -26.84%1.31B | -34.54%970.08M | -48.59%566.1M | -40.08%385.59M | 17.43%1.78B |
Cash outflows from investing activities | 3.26%306.59M | -21.60%1.11B | -30.86%740.7M | -18.92%498.33M | -26.42%296.92M | -22.90%1.41B | -29.23%1.07B | -44.73%614.64M | -37.60%403.53M | 15.36%1.83B |
Net cash flows from investing activities | -271.80%-49.35M | 947.57%104.27M | 453.92%69.41M | 576.49%132.78M | 240.53%28.73M | 95.25%-12.3M | 94.51%-19.61M | 106.48%19.63M | 93.74%-20.44M | -348.27%-258.81M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.81%1M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1M |
Cash from borrowing | 198.53%9.85M | 208.91%106.26M | --63.62M | --25.57M | --3.3M | -1.26%34.4M | ---- | ---- | ---- | --34.84M |
Cash received relating to other financing activities | --4.8M | 233.71%39.66M | --29.5M | --10.29M | ---- | 107.90%11.88M | ---- | ---- | ---- | --5.72M |
Cash inflows from financing activities | 344.11%14.66M | 215.28%145.92M | --93.12M | --35.86M | --3.3M | 11.38%46.28M | ---- | ---- | ---- | -92.22%41.56M |
Borrowing repayment | 144.69%22.28M | 644.01%82.8M | 866.80%60.52M | 371.74%29.53M | 45.43%9.1M | -61.06%11.13M | --6.26M | --6.26M | --6.26M | --28.58M |
Dividend interest payment | ---- | -24.28%85.31M | -24.37%85.21M | -29.51%79.41M | --4.59K | -14.89%112.66M | -8.62%112.66M | -8.62%112.66M | --0 | 89.30%132.37M |
Cash payments relating to other financing activities | --302.85K | 229.13%5.72M | 802.95%6.44M | 0.00%570.46K | ---- | -81.35%1.74M | -44.94%713.64K | -55.99%570.46K | ---- | -56.31%9.32M |
Cash outflows from financing activities | 147.89%22.58M | 38.48%173.83M | 27.20%152.17M | -8.35%109.51M | 45.50%9.11M | -26.28%125.53M | -3.97%119.63M | -4.09%119.49M | --6.26M | 86.59%170.27M |
Net cash flows from financing activities | -36.41%-7.92M | 64.78%-27.91M | 50.64%-59.05M | 38.36%-73.65M | 7.21%-5.81M | 38.43%-79.24M | 3.97%-119.63M | 4.09%-119.49M | ---6.26M | -129.06%-128.71M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 94.30%8.35M | 1,955.96%22.61M | 3.41%9.62M | 42.28%11.69M | 201.60%4.3M | -96.19%1.1M | -74.35%9.3M | -60.57%8.22M | -295.61%-4.23M | 457.85%28.84M |
Net increase in cash and cash equivalents | -85.68%-120.08M | 155.30%143.52M | 265.24%102.77M | 128.45%34.58M | 48.84%-64.67M | 204.64%56.22M | 68.29%-62.2M | 48.22%-121.55M | 61.29%-126.4M | -114.14%-53.72M |
Add:Begin period cash and cash equivalents | 28.69%782.77M | 10.18%608.27M | 10.18%608.27M | 10.18%608.27M | 10.18%608.27M | -8.87%552.05M | -8.87%552.05M | -8.87%552.05M | -8.87%552.05M | 168.09%605.77M |
End period cash equivalent | 21.91%662.69M | 23.60%751.79M | 45.15%711.04M | 49.32%642.85M | 27.71%543.6M | 10.18%608.27M | 19.58%489.85M | 16.03%430.5M | 52.43%425.65M | -8.87%552.05M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.